Delivery Order SPE2DR25D1205-SPE2DR26F0VT9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,043.25. The contract was competitively awarded without set-aside designation on August 26, 2025, with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray. This firm fixed price contract, awarded on August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nayzilam 5 mg nasal sprays with a contract ceiling value of $1,987.32. This firm fixed-price delivery order, which is non-competitive and set-aside-free, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $1,309.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Nayzilam 5 mg nasal sprays. The contract, which is non-set-aside and competitively awarded, is set for completion by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nayzilam 5 mg nasal sprays, a seizure rescue medication. This firm fixed-price delivery order, valued at $2,710.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $1,298.05 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with performance scheduled to conclude by October 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,218.76 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,114.51 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This firm fixed-price delivery order, issued on September 17, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $1,100 in Nayzilam 5 mg nasal sprays. This non-set-aside, competitively awarded contract employs firm fixed pricing and maintains a completion deadline of September 15, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VT9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,201.41 under firm fixed pricing. This non-set-aside contract, designated as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as the foundational contract vehicle for this delivery order and enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. This delivery order represents routine pharmaceutical procurement through AmerisourceBergen's established prime vendor relationship with DLA, consistent with the company's extensive history of competitively awarded federal medical supply contracts. Nayzilam is a nasally administered medication used for acute seizure management, reflecting the critical nature of pharmaceutical supplies procured through DLA's medical supply chain to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The rapid completion timeline and modest order value are typical of individual delivery orders issued against larger indefinite delivery contracts, demonstrating the flexibility and responsiveness required in federal medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/27/25 |